Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: INTERFERON-ALPHA - THERAPEUTIC USE , . Treffer: 32

2016

Kash, N; Massone, C; Fink-Puches, R; Cerroni, L Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.
Am J Dermatopathol. 2016; 38(7):541-545 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Spindelboeck, W; Horvath, A; Tawdrous, M; Schmerböck, B; Zettel, G; Posch, A; Streit, A; Jurse, P; Lemesch, S; Horn, M; Wuensch, G; Stiegler, P; Stauber, RE; Leber, B; Stadlbauer, V Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.
PLoS One. 2016; 11(3):e0150299-e0150299 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Baranyi, A; Meinitzer, A; Putz-Bankuti, C; Stauber, R; Kapfhammer, HP; Rothenhäusler, HB Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Psychosom Med. 2014; 76(3):197-207
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Neukam, K; Rivero, A; Puoti, M; Boesecke, C; Baumgarten, A; Grzeszczuk, A; Zangerle, R; Ernst, D; Rockstroh, JK; Trauner, M; Pineda, JA; Peck-Radosavljevic, M; Reiberger, T Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy.
Antivir Ther. 2014; 19(4):407-414
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Payer, BA; Scheiner, B; Breitenecker, F; Aichelburg, MC; Grabmeier-Pfistershammer, K; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
Liver Int. 2014; 34(1): 69-77.
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Reiberger, T; Payer, BA; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Puoti, M; Zangerle, R; Trauner, M; Peck-Radosavljevic, M Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.
J Viral Hepat. 2014; 21(1):33-41
Web of Science PubMed FullText FullText_MUG

 

Stättermayer, AF; Rutter, K; Beinhardt, S; Wrba, F; Scherzer, TM; Strasser, M; Hofer, H; Steindl-Munda, P; Trauner, M; Ferenci, P Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.
Liver Int. 2014; 34(3):388-395
Web of Science PubMed FullText FullText_MUG

 

2013

Mandorfer, M; Reiberger, T; Payer, BA; Ferlitsch, A; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Vienna HIV & Liver Study Group Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
AIDS. 2013; 27(2):227-232 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scherzer, TM; Stättermayer, AF; Stauber, R; Maieron, A; Strasser, M; Laferl, H; Schwarzer, R; Datz, C; Rutter, K; Beinhardt, S; Steindl-Munda, P; Hofer, H; Ferenci, P Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients.
J Hepatol. 2013; 59(5):964-971
Web of Science PubMed FullText FullText_MUG

 

2012

Baranyi, A; Meinitzer, A; Stepan, A; Matejka, J; Stauber, R; Kapfhammer, HP; Rothenhäusler, HB Interferon α therapy in patients with chronic hepatitis C infection: biopsychosocial consequences].
Nervenarzt. 2012; 83(9):1169-1177 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Egberts, F; Gutzmer, R; Ugurel, S; Becker, JC; Trefzer, U; Degen, A; Schenck, F; Frey, L; Wilhelm, T; Hassel, JC; Schadendorf, D; Livingstone, E; Mauch, C; Garbe, C; Berking, C; Rass, K; Mohr, P; Kaehler, KC; Weichenthal, M; Hauschild, A Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Ann Oncol. 2011; 22(7):1667-1674 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scherzer, TM; Hofer, H; Staettermayer, AF; Rutter, K; Beinhardt, S; Steindl-Munda, P; Kerschner, H; Kessler, HH; Ferenci, P Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.
J HEPATOL. 2011; 54(5): 866-871.
Web of Science PubMed FullText FullText_MUG

 

Scherzer, TM; Stättermayer, AF; Strasser, M; Laferl, H; Maieron, A; Stauber, R; Datz, C; Dulic-Lakovic, E; Steindl-Munda, P; Hofer, H; Ferenci, P Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
HEPATOLOGY. 2011; 54(5): 1518-1526. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Bodlaj, G; Hubmann, R; Saleh, K; Stojakovic, T; Biesenbach, G; Berg, J Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response.
World J Gastroenterol. 2010; 16(19): 2407-2410. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ferenci, P; Laferl, H; Scherzer, TM; Maieron, A; Hofer, H; Stauber, R; Gschwantler, M; Brunner, H; Wenisch, C; Bischof, M; Strasser, M; Datz, C; Vogel, W; Löschenberger, K; Steindl-Munda, P; Austrian Hepatitis Study Group Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response.
Gastroenterology. 2010; 138(2): 503-512.
Web of Science PubMed FullText FullText_MUG

 

2005

Richtig, E; Soyer, HP; Posch, M; Mossbacher, U; Bauer, P; Teban, L; Svolba, G; Wolf, IH; Fritsch, P; Zelger, B; Volc-Platzer, B; Gebhart, W; Mischer, P; Steiner, A; Pachinger, W; Hintner, H; Gschnait, F; Rappersberger, K; Pilarski, P; Pehamberger, H; European Cooperative Adjuvant Melanoma Treatment Study Group Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
J Clin Oncol. 2005; 23(34):8655-8663 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Wolf, IH; Smolle, J; Binder, B; Cerroni, L; Richtig, E; Kerl, H Topical imiquimod in the treatment of metastatic melanoma to skin.
Arch Dermatol. 2003; 139(3):273-276 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Constantini, PK; Wawrzynowicz-Syczewska, M; Clare, M; Boron-Kaczmarska, A; McFarlane, IG; Cramp, ME; Donaldson, PT Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy.
Liver. 2002; 22(5):404-412
Web of Science PubMed FullText FullText_MUG

 

Lackner, H; Moser, A; Benesch, M; Deutsch, J; Kessler, HH; Kerbl, R; Schwinger, W; Dornbusch, HJ; Sovinz, P; Urban, C Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
J Clin Virol. 2002; 25 Suppl 3:S73-S79
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Reinhold, U; Tilgen, W HLA-G in melanoma: A new strategy to escape from immunosurveillance?
Onkologie. 2002; 25(2):129-134
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Aberer, E; Cerroni, L; Kerl, H Cutaneous immunocytoma presenting with multiple infiltrated macules and papules.
J Am Acad Dermatol. 2001; 44(2 Suppl):324-329 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Rebmann, V; Ferrone, S; Tilgen, W; Grosse-Wilde, H; Reinhold, U Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Cancer. 2001; 92(2):369-376
Web of Science PubMed FullText FullText_MUG

 

2000

Lackner, H; Moser, A; Deutsch, J; Kessler, HH; Benesch, M; Kerbl, R; Schwinger, W; Dornbusch, HJ; Preisegger, KH; Urban, C Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy.
Pediatrics. 2000; 106(4):E53-E53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1999

Kessler, HH; Pierer, K; Santner, BI; Vellimedu, SK; Stelzl, E; Marth, E; Fickert, P; Stauber, RE Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
J Hum Virol. 1999; 1(5):314-319
PubMed

 

1998

Hilbe, W; Sill, H; Eisterer, W; Lin, F; Bechter, O; Grünewald, K; Thaler, J Long-lasting haematological remission despite persistence of the Philadelphia-positive clone in an untreated chronic myeloid leukaemia patient.
Acta Haematol. 1998; 100(2):101-103 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Schmidt, HH; Neumeister, P; Kainer, F; Karpf, EF; Linkesch, W; Sill, H Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-alpha?
Ann Hematol. 1998; 77(6):291-292
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Umlauft, F; Gruenewald, K; Weiss, G; Kessler, H; Urbanek, M; Haun, M; Santner, B; Koenig, P; Keeffe, EB Patterns of hepatitis C viremia in patients receiving hemodialysis.
Am J Gastroenterol. 1997; 92(1):73-78
Web of Science PubMed

 

1996

Kopera, D; Cerroni, L; Fink-Puches, R; Kerl, H Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome.
J Am Acad Dermatol. 1996; 34(5 Pt 2):937-939 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Gaiger, A; Henn, T; Hörth, E; Geissler, K; Mitterbauer, G; Maier-Dobersberger, T; Greinix, H; Mannhalter, C; Haas, OA; Lechner, K; Lion, T Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Blood. 1995; 86(6):2371-2378 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1994

Jörg, B; Kerl, H; Thiers, BH; Bröcker, EB; Burg, G Therapeutic approaches in cutaneous lymphoma.
Dermatol Clin. 1994; 12(2):433-441
Web of Science PubMed Google Scholar

 

1993

Niederwieser, D; Arcese, W; Bandini, G; Schwaighofer, H; Thaler, J; Bosi, A; Di Bartolomeo, P; Alessandrino, EP; Urban, C; Gratwohl, A Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
Semin Hematol. 1993; 30(3 Suppl 3):40-43
Web of Science PubMed

 

1990

Ferenci, P; Vogel, W; Pristautz, H; Deimer, J; Denk, H; Judmaier, G; Maier, KP; Krejs, GJ; Gangl, A One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b.
J Hepatol. 1990; 11 Suppl 1:S50-S53
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum